首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1316299

全球遠程患者監護市場 - 2023-2030 年

Global Remote Patient Monitoring Market - 2023-2030

出版日期: 2023年07月27日 | 出版商:

DataM Intelligence | 英文 185 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年，全球遠程患者監護市場規模達到482 億美元，預計到2030 年將實現高達3,389 億美元的豐厚成長。在預測期內（2023-2030 年），全球遠程患者監護市場的複合年成長率預計將達到28.8%。

遠程患者監護（RPM）是指在傳統醫院和醫療機構之外，利用先進的醫療物聯網（IoMT）技術收集患者數據的醫療過程。它通過創造人們對自己的健康負責的環境，改善患者的行為。

遠程病人監護設備的一些應用包括生物識別病人監護儀和虛擬護理平台。遠程患者監護設備的最新趨勢是使用雲端基礎患者監護平台，使醫療服務提供者能夠即時訪問患者數據，並為他們提供從遠程位置更好地監護患者的能力。

推動全球遠程患者監護設備發展的因素包括：慢性病發病率的上升、老年人口的增加、醫療服務可用性需求的成長、患者治療效果的改善、醫療途徑的增加以及效率的提高。

市場動態

技術進步推動遠程患者監護市場成長

遠程患者監護市場的技術進步推動了遠程患者監護系統的發展。遠程患者監護系統能夠提供遠程醫療服務，還有助於降低成本，提高醫療效果。

由於物聯網（IoT）、雲端運算和人工智慧等技術的進步，互聯醫療的解決方案也在增加。例如，基於藍牙的耳機可用於測量心率、體溫和血壓等生命徵象。它可以幫助醫生和保健從業人員從任何地點遠程監控病人。

此外，隨著智慧手機應用程式的使用，遠程病人監測變得更加高效和便捷。例如，"我的醫療"應用程式可追踪不同來源的健康資訊，包括個人醫療記錄和健身追踪數據。因此，它有助於為患者提供客製化計劃，從而推動了遠程患者監護市場的成長。

穿戴式設備在遠程患者監護市場的使用增加推動了市場成長

患者監測設備、智慧植入物和生物感測器中的穿戴式設備用於監測患者的慢性疾病，包括連續體溫監測、血糖監測、脈搏血氧儀和血壓監測。穿戴式設備擁有物聯網等新一代先進技術。

例如，Apple Watch Series 4 具有跌倒檢測和心電圖功能，最近已獲得美國食品及藥物管理局批准，可用作評估心臟健康和檢測心房顫動的非處方診斷工具。此外，Dexcom G6 和FreeStyle Libre 等血糖監測設備可幫助糖尿病患者監測血糖水準，而無需刺破手指。

這些設備通常配有專用的智慧手機應用程式，用戶可以方便地查看數據。此外，這些設備還與物聯網相連，使醫生能夠遠程監控和管理病人的病情。穿戴式生物感測器可收集血壓和心電圖等重要體徵。這些都是推動遠程病人監護市場成長的主要因素。

與安裝和培訓過程相關的高成本阻礙了市場成長

安裝遠程病人監護系統的成本包括培訓和安裝費用，根據系統的複雜程度，費用從幾百美元到幾千美元不等。舉例來說，一個僅能傳遞生命徵象的基本系統的成本可能約為或低於500 美元，而一個擁有多種系統的高級系統的成本可能超過10,000 美元。

此外，RPM 系統的維護和更新費用也應涵蓋總支出中。隨著時間的推移，定期維護、軟體升級和技術支持服務可能會產生額外費用。此外，系統的可擴展性和客製化選項也會影響其價格範圍。

更先進的功能，如即時數據分析和預測性維護功能，可能會導致成本增加。但值得一提的是，投資於一個廣泛的固體RPM 系統可帶來巨大的長期效益，如提高營運效率、減少停機時間和改善資產管理。

COVID-19 影響分析

COVID-19 大流行增加了對RPM 系統的需求。醫療保健提供商已經找到了遠程監控病人的方法，從而減少了到醫院就診的需要。因此，這導致了對RPM 技術需求的增加和採用，擴大了遠程醫療保健基礎設施，促進了遠程病人醫療保健。

RPM 系統能夠早期發現和治愈COVID-19 病例，幫助遠程管理慢性疾病，減輕醫療系統的負擔，提高患者的安全性，推動技術創新。因此，RPM 系統極大地改變了大流行期間的醫療保健服務，保證了護理的連續性，降低了暴露風險，對全球遠程病人監護市場產生了積極影響。

設備
- 生命徵象監護儀
- 血壓計
- 脈搏血氧儀
- 心率監測儀（心電圖）
- 體溫監測儀
- 呼吸頻率監護儀
- 腦監測儀（腦電圖）
- 特殊監護儀
- 麻醉監護儀
- 血糖監測儀
- 心律監測儀
- 胎心監護儀
- 凝血酶原監測儀
- 多參數監護儀(MPM)
服務與軟體

第8 章：按應用分類

心血管疾病
神經系統疾病
呼吸系統疾病
癌症
糖尿病
睡眠障礙
體重管理和體能監測
傳染病

第9 章：按最終用戶分類

支付方
醫療機構
患者

第10 章：按地區

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
南美洲
- 巴西
- 阿根廷
- 南美洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 澳大利亞
- 亞太其他地區
中東和非洲

第11 章：競爭格局

競爭格局
市場定位/佔有率分析
合併與收購分析

第十二章：公司簡介

Medtronic Plc
- 公司概況
- 產品組合和說明
- 財務概況
- 近期發展
Koninklijke Philips NV
GE Healthcare
Abbott Laboratories
BioTelemetry Inc.
Siemens Healthineers AG
Boston Scientific Corporation
Welch Allyn
OMRON Healthcare Co., Ltd.
Transtek

第13 章：附錄

簡介目錄

Product Code: MD74

Market Overview

The global remote patient monitoring market reached US$ 48.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 338.9 billion by 2030. The global remote patient monitoring market is expected to exhibit a CAGR of 28.8% during the forecast period (2023-2030).

Remote patient monitoring (RPM) is the healthcare process that uses Internet of medical things (IoMT) advancements for collecting patient data outside the traditional hospital and healthcare setup. It improves patient behaviour by creating the surrounding by which people are accountable and responsible for their health.

Some of the applications of remote patient monitoring devices are Biometric Patient Monitors and Virtual Care Platforms. The recent trends that are seen in remote patient monitoring devices are the use of cloud-based patient monitoring platforms allowing healthcare providers to access patient data in real-time and providing them with the ability to better monitor patients from remote locations.

The global remote patient monitoring is driven by the factors such as increasing prevalance of chronic disease, increase in the geriatric population and growing demands expansion in healthcare service avaliability, improved patient outcomes, increased access to care, increased efficiency.

Market Dynamics

Technological Advancements is Driving the Growth of Remote Patient Monitoring Market

The remote patient monitoring market has seen a rise in technology-driven advancements that are driving the growth of remote patient monitoring systems. Remote patient monitoring has the ability to provide access to healthcare from remote locations and also it helps reduce costs improving the results.

Solutions for connected health have increased due to the advancements in technologies such as the Internet of Things (IoT), Cloud Computing, and artificial intelligence. For instance, Bluetooth-based headsets are being used to measure vital signs such as heart rate, body temperature, and blood pressure. It helps doctors and healthcare practitioners to monitor patients remotely from any location.

Furthermore, with the use of smartphone apps, remote patient monitoring is becoming efficient and easier. For instance, My medical app tracks health information from different sources which includes personal medical records and fitness tracking data. Thus, it is useful to provide a customized plan for the patient and thus technological advancements are driving the growth of the remote patient monitoring market.

Increase in the Use of Wearables in Remote Patient Monitoring Market is Driving the Growth

Wearables in patient monitoring devices, smart implants and biosensors are used for monitoring chronic disease in the patient which includes continuous temperature monitoring, glucose monitoring, pulse oximetry and blood pressure monitoring. The wearables have next-generation advanced technologies such as the Internet of Things.

For instance, the Apple Watch Series 4, with its Fall Detection and ECG features, has recently been cleared by the FDA for use as an over-the-counter diagnostic tool for assessing cardiac health and detecting atrial fibrillation. Additionally, glucose monitoring devices such as the Dexcom G6 and FreeStyle Libre help diabetics to monitor their blood sugar levels without having to prick their fingers.

These devices often come with dedicated smartphone apps that allow users to conveniently view their data. Furthermore, these devices are connected to the Internet of Things, allowing physicians to remotely monitor and manage the conditions of their patients. Wearable biosensors collect important signs such as blood pressure, and electrocardiography. These are major factors which are driving the growth of the remote patient monitoring market.

High Cost Associated with the Installation and Training Process for RPM to Hamper the Market Growth

The cost of installing an remote patient monitoring system includes the cost of training and installation, which can range from a few hundred dollars to several thousand dollars depending on the system's complexity. A basic system that just communicates vital signs, for instance, may cost approximately or less than $500, whereas an advanced system with a wide range of systems may cost more than $10,000.

In addition, the cost of maintaining and updating the RPM system should be incorporated into the overall expenses. Over time, regular maintenance, software upgrades, and technical support services may incur additional costs. Furthermore, the scalability and customization options of the system can influence its price range.

More advanced features, such as real-time data analysis and predictive maintenance capabilities, may contribute to a higher cost. It is worth mentioning that however, that investing in an extensive solid RPM system can result in substantial long-term benefits such as greater operational efficiency, decreased downtime, and improved asset management.

COVID-19 Impact Analysis

The COVID-19 pandemic has increased the demand for RPM systems. Healthcare providers have found ways to remotely monitor patients,reducing the need for hospital visits. It has thus led to the increase in demand and adoption of RPM technology, expansion of telehealthcare infrastructure and facilitated remote patient healthcare.

RPM systems enabled early detection and cure of COVID-19 cases, helping managethe chronic conditions remotely reducing the burden on healthcare systems, enhancing the safety of the patient and driving innovation in technology. As a result, RPM systems have significantly transformed the delivery of healthcare during the pandemic by continuity of care and reduction of exposure risks and positively impacting the global remote patient monitoring market.

Segment Analysis

The global remote patient monitoring market is segmented based on product type, application, end-user and region.

Device Segment to Dominate the Market Owing to the Growing Adoption of Connected Devices

The device segment is expected to dominate the remote patient monitoring market with the market share of about 40.3% over the forecast period. The factors driving the device segment include increasing need for home healthcare, the increasing prevalence of chronic diseases and the growing adoption of connected devices.

For instance, in April, 26 2023, CardieX received FDA 510(K) clearance for a world-first vascular biometric monitor- the CONNEQT pulse, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Pulse is the only vital signs monitor targated at home, clinician, and clinical trial use measurements of both brachial blood pressure (the pressure at your arm) and central blood pressure (the pressure at your aorta/heart) in addition to multiple other vascular health biomarkers.

Geographical Analysis

North America's Region Dominating the Market Owing to the Increase in Adoption of Connected Healthcare Technology

Remote patient monitoring system is becoming increasingly popular in North America and the region is dominating the industry in a variety of ways with market share of about 41.1%. The North American region has dominated and is expected to dominate the remote patient monitoring system due to the increasing adoption of connected healthcare technology and the presence of top and leading market players in the region.

For instance, Medtronic recently announced the launch of its new Carelink Connected Remote Monitoring System which allows patients and healthcare providers to stay connected and collaborate in real-time. Similarly, Philips Healthcare has long been investing in services and technology related to remote monitoring systems.

The key drivers of market growth in the North American region include increasing demand for home healthcare services, increasing internet penetration, favourable government initiatives and the geriatric population. Moreover, the region has seen a rise in the no of hospitals introducing telehealth solutions, with the U.S. leading the way in the segment. For instance, Medicare and Medicaid Services (CMS) initiatives encourage doctors and other healthcare practitioners to embrace telehealth technologies.

Furthermore, the Department of Veterans Affairs in the United States has initiated a number of projects to boost the use of telehealth services, and the US government has provided incentives to institutions that use telehealth services. These measures have expanded telehealth usage in North America, adding to the overall growth of the market.

This has spurred the growth of the home healthcare services market, allowing the elderly to obtain quality healthcare services in the comfort of their own homes. With efforts such as the Department of Defence, the United States has been at the forefront of this expansion. Veterans Affairs and CMS are at the forefront of the telehealth sector.

Competitive Landscape

The major global players include: Medtronic Plc, Koninklijke Philips N.V, GE Healthcare, Abbott Laboratories, BioTelemetry Inc., Siemens Healthineers AG Boston Scientific Corporation, Welch Allyn, OMRON Healthcare Co., Ltd., Transtek among others.

Why Purchase the Report?

To visualize the global remote patient monitoring market segmentation based on product type, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of remote patient monitoring market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global remote patient monitoring market report would provide approximately 61 tables, 61 figures and 185 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing prevalence of chronic diseases
  - 4.1.1.2. Increase in the geriatric population and growing need demands expansion in healthcare service availability
- 4.1.2. Restraints
  - 4.1.2.1. Lack of remote monitoring solution in low-income countries
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Devices*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 7.2.2.1. Vital Sign Monitors
  - 7.2.2.1.1. Blood Pressure Monitors
  - 7.2.2.1.2. Pulse Oximeters
  - 7.2.2.1.3. Heart Rate Monitor (ECG)
  - 7.2.2.1.4. Temperature Monitor
  - 7.2.2.1.5. Respiratory Rate Monitor
  - 7.2.2.1.6. Brain Monitor (EEG)
  - 7.2.2.2. Special Monitors
  - 7.2.2.2.1. Anesthesia Monitors
  - 7.2.2.2.2. Blood Glucose Monitors
  - 7.2.2.2.3. Cardiac Rhythm Monitors
  - 7.2.2.2.4. Fetal Heart Monitors
  - 7.2.2.2.5. Prothrombin Monitors
  - 7.2.2.2.6. Multi-Parameter Monitors (MPM)
7.3. Services & Software

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Cardiovascular Diseases*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Neurological Disorders
8.4. Respiratory Disorders
8.5. Cancer
8.6. Diabetes
8.7. Sleep Disorder
8.8. Weight management and Fitness Monitoring
8.9. Infectious Diseases

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Payers*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Providers
9.4. Patients

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Medtronic Plc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Recent Developments
12.2. Koninklijke Philips N.V
12.3. GE Healthcare
12.4. Abbott Laboratories
12.5. BioTelemetry Inc.
12.6. Siemens Healthineers AG
12.7. Boston Scientific Corporation
12.8. Welch Allyn
12.9. OMRON Healthcare Co., Ltd.
12.10. Transtek

LIST NOT EXHAUSTIVE